Human medicines European public assessment report (EPAR): Zelboraf, vemurafenib, Date of authorisation: 17/02/2012, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Zelboraf, vemurafenib, Date of authorisation: 17/02/2012, Revision: 25, Status: Authorised

Abstract Book 2024 is coming - sign up to the EJCRIM free alert service

The team of the European Case Reports Journal in Internal Medicine, EJCRIM is in process of preparing the Book of Abstracts from the 22nd European Congress of Internal Medicine (Istanbul, 6–9 March).
The abstract book will be published on the EJCRIM website in the coming weeks!

If you want to be notified when the book will be online, sign up to the  EJCRIM free alert service here.

 

Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), Date of authorisation: 11/03/2021, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), Date of authorisation: 11/03/2021, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Pravafenix, fenofibrate,pravastatin, Date of authorisation: 14/04/2011, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Pravafenix, fenofibrate,pravastatin, Date of authorisation: 14/04/2011, Revision: 9, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness